Physician profile
John K Park
NPI 1558454637
$2,772.88
in general payments reported to CMS, 2019-2025
10 companies · $96.69 in 2025
The $96.69 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $55.98 · 2021: $258 · 2022: $531 · 2023: $53.87 · 2024: $1,777 · 2025: $96.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,582 · Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,582.15 |
| Food and Beverage | $345.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,627.09 | 2024 | Everest Spinal System |
| Medtronic, INC. | $346.92 | 2021-2022 | |
| Penumbra, INC. | $300.93 | 2023-2025 | Red 72, Penumbra System |
| Abbott Laboratories | $201.27 | 2022 | |
| Depuy Synthes Sales INC. | $149.98 | 2022 | |
| Horizon Therapeutics Plc | $65.71 | 2022 | |
| Medtronic Vascular, INC. | $26.82 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 2021 | |
| Si-Bone, INC. | $16.43 | 2020 | |
| Medtronic USA, INC. | $12.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.